Rosati A

No ORCID on file · 11 papers in corpus
review 2026
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics16121899

Background/Objectives: Hysteroscopy is the gold standard for visualization and treatment of intrauterine pathology. Because hysteroscopic interpretation remains operator-dependent, artificial intelligence (AI) has been evaluated as a tool t…

meta-analysis 2025
International journal of molecular sciences ·doi:10.3390/ijms262110713

Adenomyosis (AM) is a hormonally responsive uterine disorder defined by ectopic endometrial tissue within the myometrium, causing pain, abnormal bleeding, and subfertility. Non-coding RNAs (ncRNAs)-including microRNAs (miRNAs), long non-cod…

meta-analysis 2025
Journal of robotic surgery ·doi:10.1007/s11701-025-02973-3

INTRODUCTION: The Hugo™ Robotic-Assisted Surgery (RAS) system is a recent development in minimally invasive gynecologic surgery. Following regulatory approval, its clinical use has expanded. However, comprehensive evidence on feasibility, s…

review 2025
Facts, views & vision in ObGyn ·doi:10.52054/fvvo.2024.13522

BACKGROUND: Several new robotic platforms are being commercialised, with different features in terms of types of consoles, numbers of arms, and targeting transabdominal or natural orifice approaches. The benefits of robotic surgery over lap…

other 2024
Facts, views & vision in ObGyn ·doi:10.52054/fvvo.16.4.052

BACKGROUND: In 2022, OpenAI launched ChatGPT 3.5, which is now widely used in medical education, training, and research. Despite its valuable use for the generation of information, concerns persist about its authenticity and accuracy. Its u…

review 2024
Facts, views & vision in ObGyn ·doi:10.52054/fvvo.16.2.024

BACKGROUND: More than two decades ago, the advent of robotic laparoscopic surgery marked a significant milestone, featuring the introduction of the AESOP robotic endoscope control system and the ZEUS robotic surgery system. The latter, equi…

case-report 2024
Journal of personalized medicine ·doi:10.3390/jpm14101052

BACKGROUND: Most patients with ovarian cancer relapse within 2 years. Prospective randomized trials, such as DESKTOP III and SOC-I, have shown the role of secondary cytoreduction in improving oncological outcomes in selected patients, when …

observational 2022
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.14089

OBJECTIVE: To evaluate the functional outcomes of nerve-sparing surgery for deep infiltrating endometriosis (DIE) with or without posterolateral parametrectomy. METHODS: A multicenter, observational, retrospective, cohort study was perform…

other 2022
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.14402

OBJECTIVE: To investigate the feasibility and the efficacy of laparoscopic ureteroneocystostomy with round ligament bladder hitching. METHODS: This is a monocentric retrospective study. Enrolled patients affected by deep endometriosis unde…

other 2022
Facts, views & vision in ObGyn ·doi:10.52054/fvvo.14.2.016

BACKGROUND: Deep endometriosis (DE) usually creates a distortion of the retroperitoneal anatomy and may infiltrate the parametria with an oncomimetic pathway similar to cervical cancer. The condition represents a severe manifestation of end…

rct 2021
Facts, views & vision in ObGyn ·doi:10.52054/fvvo.13.3.027

BACKGROUND: The introduction of ultra-high-definition laparoscopic cameras (4K), by providing stronger monocular depth perception, could challenge the existing 3D technology. There are few available studies on this topic, especially in gyna…